Joint support Complex to Assist Mobility
Ingredients in Glucosamine Intensive Care have been shown to or may:
- Protect joint cartilage in mild osteoarthritis.
- Support knee joint mobility and range of movement in athletes: Glucosamine has been shown, in a randomised, placebo-controlled double-blind trial, to support joint mobility for sports knee injuries in athletes. Athletes with a recent knee injury were given 1500 mg glucosamine per day and after 28 days there was significant improvement in knee flexion and extension in those taking glucosamine compared with placebo. This may be due to its function in reducing collagen breakdown associated with exercise.
- Convenient, twice daily tablet for improved compliance.
Adults: Take 1 tablet twice daily with food.
|
Each tablet contains: |
|
|
Glucosamine sulfate sodium chloride |
942 mg |
|
Equivalent Glucosamine sulfate |
750 mg |
|
Colloidal anhydrous silica |
20 mg |
|
Zinc amino acid chelate (Meta Zn® – Zinc bisglycinate) |
50 mg |
|
Equivalent Zinc |
10 mg |
|
Manganese amino acid chelate |
47 mg |
|
Equivalent Manganese |
7.5 mg |
|
Borax (Sodium borate) |
13 mg |
|
Equivalent Boron |
1.5 mg |
Free from dairy protein, lactose, eggs, gluten, wheat, nuts, yeast and soy protein. Free from artificial colours, flavours and preservatives. Contains 129 mg of potassium. Contains crustacean products and glucosamine derived from seafood.
Contains glucosamine derived from seafood.
Not to be taken by children under 2 years old. Contains 129 mg of potassium. If you have kidney disease or are taking heart or blood pressure medicines, consult your doctor or pharmacist before use. Keep out of reach of children.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.
Joint support Complex to Assist Mobility
Ingredients in Glucosamine Intensive Care have been shown to or may:
- Protect joint cartilage in mild osteoarthritis.
- Support knee joint mobility and range of movement in athletes: Glucosamine has been shown, in a randomised, placebo-controlled double-blind trial, to support joint mobility for sports knee injuries in athletes. Athletes with a recent knee injury were given 1500 mg glucosamine per day and after 28 days there was significant improvement in knee flexion and extension in those taking glucosamine compared with placebo. This may be due to its function in reducing collagen breakdown associated with exercise.
- Convenient, twice daily tablet for improved compliance.
Adults: Take 1 tablet twice daily with food.
|
Each tablet contains: |
|
|
Glucosamine sulfate sodium chloride |
942 mg |
|
Equivalent Glucosamine sulfate |
750 mg |
|
Colloidal anhydrous silica |
20 mg |
|
Zinc amino acid chelate (Meta Zn® – Zinc bisglycinate) |
50 mg |
|
Equivalent Zinc |
10 mg |
|
Manganese amino acid chelate |
47 mg |
|
Equivalent Manganese |
7.5 mg |
|
Borax (Sodium borate) |
13 mg |
|
Equivalent Boron |
1.5 mg |
Free from dairy protein, lactose, eggs, gluten, wheat, nuts, yeast and soy protein. Free from artificial colours, flavours and preservatives. Contains 129 mg of potassium. Contains crustacean products and glucosamine derived from seafood.
Contains glucosamine derived from seafood.
Not to be taken by children under 2 years old. Contains 129 mg of potassium. If you have kidney disease or are taking heart or blood pressure medicines, consult your doctor or pharmacist before use. Keep out of reach of children.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.